Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Abhinav Bassi"'
Autor:
Shani S. Thankachen, Niveditha Devasenapathy, Abhinav Bassi, Arpita Ghosh, Sumaiya Arfin, Balaji Gummidi, Aneesh Basheer, Ashfak Bangi, Dibakar Sahu, Ashish Bhalla, Merlin Blesson, Manish Jain, Vivekanand Jha
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background There is no known effective pharmacological therapy for long COVID, which is characterized by wide-ranging, multisystemic, fluctuating, or relapsing symptoms in a large proportion of survivors of acute COVID. This randomized contr
Externí odkaz:
https://doaj.org/article/82e38d79cd564a4fbec8ee44bf492341
Autor:
Carinna Hockham, Sradha Kotwal, Arlen Wilcox, Abhinav Bassi, James McGree, Carol Pollock, Louise M. Burrell, Nikita Bathla, Mallikarjuna Kunigari, Vinay Rathore, Michael John, Enmoore Lin, Christine Jenkins, Angus Ritchie, Andrew McLachlan, Thomas Snelling, Mark Jones, Vivekanand Jha, Meg Jardine, on behalf of the CLARITY Investigators
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-11 (2021)
Abstract Background SARS-CoV-2 binds to membrane-bound angiotensin-converting enzyme 2 (ACE2) which may result in downregulation of membrane-bound ACE2. ACE2 is a key regulator of the renin-angiotensin system (RAS) and is responsible for degrading an
Externí odkaz:
https://doaj.org/article/895cf329e32e4301a5d54c35a2ed5b69
Autor:
Rohina Joshi, Sudha Vidyasagar, Niveditha Devasenapathy, Rinaldo Bellomo, Vivekanand Jha, Chirag Patel, Vijay Kumar, Lachlan Donaldson, Oommen John, Balasubramanian Venkatesh, Michael John, Naomi Hammond, Jeyaraj Pandian, Ashwani Kumar, Arpita Ghosh, S Radhakrishnan, Rajib Paul, Bharath Kumar Tirupakuzhi Vijayaraghavan, Dorrilyn Rajbhandari, Sheila Nainan Myatra, Amritendu Bhattacharya, Sumaiya Arfin, Abhinav Bassi, Lachlan Hugh Donaldson, Naomi E Hammond, Mallikarjuna Kunigari, Cynthia Amrutha, Syed Haider Mehdi Husaini, Subir Ghosh, Santosh Kumar Nag, Hari Krishnan Selvaraj, Viny Kantroo, Kamal D Shah, Sheila Myatra, Amritendu Battacharya, Pavan Kumar Vecham, Evangeline Elvira, Gomathi Parthasarathy, Archana Ragunathan, Gnanavel Rajendra Kunjurao, Pavithra Sampath Kumar, Hilda Nirmala Kumari, Jayanthi Swaminathan, Murshid Cheriyeri Peediyekkal, Arun Chander Yadav, Aarthi Venkatramanan, Cynthia Amrutha Sukumar, Dharini Prasad, Krishnanda Nayak, Ravindra Prabhu, Rohini Bilagi, Akash Bhange, Bhumika Patel, Ekta Ramchandani, Jinesh Patel, Krupa Gandhi, N Prathyusha, Rayshma Rao Bonshlay Lakshmanan, S Hari Krishnan, Abhishek George Mehta, Mousumi Pradhan, Shahid Ali Siddique, Naved-ur Rahman, Mohammad Jamalludeen, Mounika Amarneni, Suresh Sankar, Vidya Rajesh Joshi, Alka Yadav, Nikhil Modi, Rinku Dahiya, Serena Knowles, Nikita Bathla, Fatima Butt
Publikováno v:
BMJ Open, Vol 12, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/ae3415ae970048db8f849ec9a7de9ad3
Autor:
Oommen John, Balaji Gummidi, Abha Tewari, J.P. Muliyil, Arpita Ghosh, Meena Sehgal, Abhinav Bassi, Shankar Prinja, Vivek Kumar, Om P. Kalra, Vijay Kher, J.S. Thakur, Lakshmy Ramakrishnan, C.M. Pandey, V. Sivakumar, R.S. Dhaliwal, Tripti Khanna, Aruna Kumari, Jitender Sharma, Poonam Malakondiah, Vivekanand Jha
Publikováno v:
Kidney International Reports, Vol 4, Iss 10, Pp 1412-1419 (2019)
Introduction: High prevalence of chronic kidney disease (CKD) not associated with known risk factors has been reported from coastal districts of Andhra Pradesh. The Study to Test and Operationalize Preventive Approaches for Chronic Kidney Disease of
Externí odkaz:
https://doaj.org/article/15bd3fb871e84d06b6e4937cea2a3ef9
Autor:
Bharath Kumar Tirupakuzhi Vijayaraghavan, Vivekanand Jha, Dorrilyn Rajbhandari, Sheila Nainan Myatra, Oommen John, Arpita Ghosh, Abhinav Bassi, Sumaiya Arfin, Mallikarjuna Kunigari, Rohina Joshi, Lachlan Donaldson, Naomi Hammond, Balasubramanian Venkatesh, the HOPE investigators
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-3 (2020)
Abstract Objectives To evaluate the effect of the combination of hydroxychloroquine (HCQ) and standard personal protective equipment (PPE) compared to the use of standard personal protective equipment alone on the proportion of laboratory confirmed C
Externí odkaz:
https://doaj.org/article/9d3b7b7477574b3ea0b99ab86894b2b2
Autor:
Abhinav Bassi, Sumaiya Arfin, Oommen John, Devarsetty Praveen, Varun Arora, O.P. Kalra, S. V. Madhu, Vivekanand Jha
Publikováno v:
International Journal of Diabetes in Developing Countries. 43:353-362
Background India has 66 million people with diabetes, of which a large proportion do not receive adequate care. The primary health centres can serve as platforms for early detection of diabetes and continuum of care. Objectives This project evaluates
Autor:
Meg J, Jardine, Sradha S, Kotwal, Abhinav, Bassi, Carinna, Hockham, Mark, Jones, Arlen, Wilcox, Carol, Pollock, Louise M, Burrell, James, McGree, Vinay, Rathore, Christine R, Jenkins, Lalit, Gupta, Angus, Ritchie, Ashpak, Bangi, Sanjay, D'Cruz, Andrew J, McLachlan, Simon, Finfer, Michelle M, Cummins, Thomas, Snelling, Vivekanand, Jha, Saurabh, Nayak
Publikováno v:
BMJ (Clinical research ed.). 379
Objective To determine whether disrupting the renin angiotensin system with angiotensin receptor blockers will improve clinical outcomes in people with covid-19. Design CLARITY was a pragmatic, adaptive, multicentre, phase 3, randomised controlled tr
Autor:
Bharath Kumar, Tirupakuzhi Vijayaraghavan, Vivekanand, Jha, Dorrilyn, Rajbhandari, Sheila Nainan, Myatra, Arpita, Ghosh, Amritendu, Bhattacharya, Sumaiya, Arfin, Abhinav, Bassi, Lachlan Hugh, Donaldson, Naomi E, Hammond, Oommen, John, Rohina, Joshi, Mallikarjuna, Kunigari, Cynthia, Amrutha, Syed Haider Mehdi, Husaini, Subir, Ghosh, Santosh Kumar, Nag, Hari Krishnan, Selvaraj, Viny, Kantroo, Kamal D, Shah, Balasubramanian, Venkatesh, Fatima, Butt
Publikováno v:
BMJ open. 12(6)
ObjectivesTo determine whether hydroxychloroquine when used with personal protective equipment reduces the proportion of laboratory-confirmed COVID-19 among healthcare workers in comparison to the use of personal protective equipment alone.DesignMult
Autor:
Anders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, Sheila Nainan Myatra, Bharath Kumar Tirupakuzhi Vijayaraghavan, Maria Cronhjort, Rebecka Rubenson Wahlin, Stephan M. Jakob, Luca Cioccari, Gitte Kingo Vesterlund, Tine Sylvest Meyhoff, Marie Helleberg, Morten Hylander Møller, Thomas Benfield, Balasubramanian Venkatesh, Naomi E. Hammond, Sharon Micallef, Abhinav Bassi, Oommen John, Vivekanand Jha, Klaus Tjelle Kristiansen, Charlotte Suppli Ulrik, Vibeke Lind Jørgensen, Margit Smitt, Morten H. Bestle, Anne Sofie Andreasen, Lone Musaeus Poulsen, Bodil Steen Rasmussen, Anne Craveiro Brøchner, Thomas Strøm, Anders Møller, Mohd Saif Khan, Ajay Padmanaban, Jigeeshu Vasishtha Divatia, Sanjith Saseedharan, Kapil Borawake, Farhad Kapadia, Subhal Dixit, Rajesh Chawla, Urvi Shukla, Pravin Amin, Michelle S. Chew, Christian Aage Wamberg, Neeta Bose, Mehul S. Shah, Iben S. Darfelt, Christian Gluud, Theis Lange, Anders Perner
Publikováno v:
Granholm, A, Kjær, M-B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Møller, A, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580–589 . https://doi.org/10.1007/s00134-022-06677-2
Granholm, A, Kjær, M B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Møller, A, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580-589 . https://doi.org/10.1007/s00134-022-06677-2
Granholm, A, Kjær, M-B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580-589 . https://doi.org/10.1007/s00134-022-06677-2
Granholm, A, Kjær, M B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Møller, A, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580-589 . https://doi.org/10.1007/s00134-022-06677-2
Granholm, A, Kjær, M-B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580-589 . https://doi.org/10.1007/s00134-022-06677-2
PURPOSE: We assessed long-term outcomes of dexamethasone 12 mg versus 6 mg given daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia.METHODS: We assessed 180-day mortality and health-related quality of l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a03aca1ede6095b26a7bc6659898e2a
Autor:
Abhinav Bassi, Sumaiya Arfin, Rohina Joshi, Nikita Bathla, Naomi E Hammond, Dorrilyn Rajbhandari, Bharath Kumar Tirupakuzhi Vijayaraghavan, Balasubramanian Venkatesh, Vivekanand Jha
Publikováno v:
The Lancet. Global Health